Recombinant Human Hepatocyte Growth Factor Promotes Functional Recovery After Spinal Cord Injury

Author(s):  
Kazuya Kitamura ◽  
Akio Iwanami ◽  
Kanehiro Fujiyoshi ◽  
Jun-ichi Yamane ◽  
Keigo Hikishima ◽  
...  
PLoS ONE ◽  
2011 ◽  
Vol 6 (11) ◽  
pp. e27706 ◽  
Author(s):  
Kazuya Kitamura ◽  
Kanehiro Fujiyoshi ◽  
Jun-ichi Yamane ◽  
Fumika Toyota ◽  
Keigo Hikishima ◽  
...  

2007 ◽  
Vol 85 (11) ◽  
pp. 2332-2342 ◽  
Author(s):  
Kazuya Kitamura ◽  
Akio Iwanami ◽  
Masaya Nakamura ◽  
Junichi Yamane ◽  
Kota Watanabe ◽  
...  

2019 ◽  
Vol 20 (23) ◽  
pp. 6078 ◽  
Author(s):  
Kentaro Yamane ◽  
Haruo Misawa ◽  
Tomoyuki Takigawa ◽  
Yoshihiro Ito ◽  
Toshifumi Ozaki ◽  
...  

Spinal cord injury (SCI) results in neural tissue loss and so far untreatable functional impairment. In addition, at the initial injury site, inflammation induces secondary damage, and glial scar formation occurs to limit inflammation-mediated tissue damage. Consequently, it obstructs neural regeneration. Many studies have been conducted in the field of SCI; however, no satisfactory treatment has been established to date. Hepatocyte growth factor (HGF) is one of the neurotrophic growth factors and has been listed as a candidate medicine for SCI treatment. The highlighted effects of HGF on neural regeneration are associated with its anti-inflammatory and anti-fibrotic activities. Moreover, HGF exerts positive effects on transplanted stem cell differentiation into neurons. This paper reviews the mechanisms underlying the therapeutic effects of HGF in SCI recovery, and introduces recent advances in the clinical applications of HGF therapy.


2019 ◽  
Vol 20 (5) ◽  
pp. 1054 ◽  
Author(s):  
Kazuya Kitamura ◽  
Narihito Nagoshi ◽  
Osahiko Tsuji ◽  
Morio Matsumoto ◽  
Hideyuki Okano ◽  
...  

Hepatocyte growth factor (HGF) was first identified as a potent mitogen for mature hepatocytes, and has also gained attention as a strong neurotrophic factor in the central nervous system. We found that during the acute phase of spinal cord injury (SCI) in rats, c-Met, the specific receptor for HGF, increases sharply, while the endogenous HGF up-regulation is relatively weak. Introducing exogenous HGF into the spinal cord by injecting an HGF-expressing viral vector significantly increased the neuron and oligodendrocyte survival, angiogenesis, and axonal regeneration, to reduce the area of damage and to promote functional recovery in rats after SCI. Other recent studies in rodents have shown that exogenously administered HGF during the acute phase of SCI reduces astrocyte activation to decrease glial scar formation, and exerts anti-inflammatory effects to reduce leukocyte infiltration. We also reported that the intrathecal infusion of recombinant human HGF (intrathecal rhHGF) improves neurological hand function after cervical contusive SCI in the common marmoset, a non-human primate. Based on these collective results, we conducted a phase I/II clinical trial of intrathecal rhHGF for patients with acute cervical SCI who showed a modified Frankel grade of A/B1/B2 72 h after injury onset, from June 2014 to May 2018.


2012 ◽  
Vol 233 (1) ◽  
pp. 312-322 ◽  
Author(s):  
Soo Ryeong Jeong ◽  
Min Jung Kwon ◽  
Hwan Goo Lee ◽  
Eun Hye Joe ◽  
Jae Ho Lee ◽  
...  

2007 ◽  
Vol 1151 ◽  
pp. 188-194 ◽  
Author(s):  
Munehisa Shimamura ◽  
Naoyuki Sato ◽  
Masataka Sata ◽  
Kouji Wakayama ◽  
Toshio Ogihara ◽  
...  

Nature ◽  
1989 ◽  
Vol 342 (6248) ◽  
pp. 440-443 ◽  
Author(s):  
Toshikazu Nakamura ◽  
Tsutomu Nishizawa ◽  
Mitchio Hagiya ◽  
Tatsuya Seki ◽  
Manabu Shimonishi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document